Page last updated: 2024-08-22

cladribine and Scleroderma, Systemic

cladribine has been researched along with Scleroderma, Systemic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Błaszczyk, M; Chorzelski, T; Grieb, P; Jabłońska, S; Majewski, S; Ryba, M; Skopińska, M	1
Davis, LS; Sanal, S; Sangueza, OP	1

Trials

1 trial(s) available for cladribine and Scleroderma, Systemic

Article	Year
Systemic administration of 2-chloro-2'-deoxyadenosine (2-CdA) in patients with systemic scleroderma. Archivum immunologiae et therapiae experimentalis, 1994, Volume: 42, Issue:1 Topics: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cladribine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Scleroderma, Systemic; T-Lymphocyte Subsets	1994

Article

Year

Systemic administration of 2-chloro-2'-deoxyadenosine (2-CdA) in patients with systemic scleroderma.

Archivum immunologiae et therapiae experimentalis, 1994, Volume: 42, Issue:1

Topics: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cladribine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Scleroderma, Systemic; T-Lymphocyte Subsets

1994

Other Studies

1 other study(ies) available for cladribine and Scleroderma, Systemic

Article	Year
Treatment of scleromyxedema with 2-chlorodeoxyadenosine. Journal of the American Academy of Dermatology, 1996, Volume: 35, Issue:2 Pt 2 Topics: Cladribine; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Myxedema; Scleroderma, Systemic	1996